TSS
MTCR

Two Sigma Securities’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Two Sigma Securities’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-69,435
Closed -$31.1K – 3494
2022
Q4 		$31.1K Buy
+69,435
New +$28.7K ﹤0.01% 2225

Other funds holding MTCR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Two Sigma Securities's MTCR Position: Q1 2023 in Review

Two Sigma Securities sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 69,435 shares — an estimated $31.1K sold.

Two Sigma Securities first reported a position in MTCR in Q4 2022 and held it in 1 quarter. The position peaked at $31.1K in Q4 2022. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

  • Two Sigma Securities reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 69,435 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $31.1K.
  • Two Sigma Securities first reported a position in Metacrine, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Two Sigma Securities's Metacrine, Inc. Common Stock position peaked at $31.1K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.